1492-14-4

Usage

Uses

Used in Pharmaceutical Industry:
(2S)-methyl 2-N-benzoylaminopentanoate is used as an intermediate in the synthesis of various pharmaceuticals for its ability to be incorporated into the structure of anticoagulants and anti-inflammatory drugs. Its presence in these medications aids in their therapeutic effects.
Used in Chemical Industry:
(2S)-methyl 2-N-benzoylaminopentanoate is used as a precursor for the preparation of other complex molecules, thanks to the benzoyl group in its structure, which is useful in organic synthesis reactions.
Used in Research and Development:
(2S)-methyl 2-N-benzoylaminopentanoate is used as a research compound for the development of new drug candidates, where its unique structure and properties can be leveraged to create novel therapeutic agents.

Upstream product

• 170454-17-8 (2Z)-methyl 2-N-benzoylaminopenta-2,4-dienoate 
• 120341-28-8 Methyl 2-(N-Benzoylamino)-2-(dimethoxyphosphinyl)ethanoate 
• 21286-78-2 methyl N-benzoyl-2-methoxyglycinate 
• 19791-95-8 α-hydroxyhippuric acid 
• 55-21-0 benzamide 
• 98-88-4 benzoyl chloride 

Relevant academic research and scientific papers

Methods for the synthesis of dicarba bridges in organic compounds

The present invention relates to methods for forming dicarba bridges in organic compounds. This involves the use of a pair of complementary metathesisable groups on the organic compound, and subjecting the compound to cross-metathesis under microwave radiation conditions. In an alternative, the compounds contain a turn-inducing group between the pair of cross-metathesisable groups to facilitate the cross-metathesis.

Efficient synthesis of optically active α-quaternary amino acids by highly diastereoselective [2,3]-rearrangement of allylic ammonium ylides

A pincer-like chiral auxiliary strategy for synthesizing various optically active α,α-disubstituted amino acids in high yields with excellent enantioselectivities is described.

Conotoxin analogues and methods for synthesis of intramolecular dicarba bridge-containing peptides

According to the present invention, there is provided a range of new conotoxin derivatives and methods for synthesizing these analogues and other intramolecular dicarba bridge-containing peptides, including dicarba-disulfide bridge-containing peptides.